Cargando…
CHA(2)DS(2)-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation
AIMS: TIMI risk score and GRACE risk model are widely available and accepted scores for risk assessment in STEMI patients and include predictors of poor outcomes. CHA(2)DS(2)-VASc is a validated score for predicting embolic/stroke risk in patients with non-valvular atrial fibrillation. Its component...
Autores principales: | Hudzik, Bartosz, Szkodziński, Janusz, Hawranek, Michal, Lekston, Andrzej, Poloński, Lech, Gąsior, Mariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014889/ https://www.ncbi.nlm.nih.gov/pubmed/27339195 http://dx.doi.org/10.1007/s00592-016-0877-6 |
Ejemplares similares
-
Testing for antiphospholipid antibodies at autopsy
por: Hudzik, Bartosz, et al.
Publicado: (2014) -
Prognostic impact of multimorbidity in patients with type 2 diabetes and ST-elevation myocardial infarction
por: Hudzik, Bartosz, et al.
Publicado: (2017) -
CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018) -
Single nucleotide polymorphisms for genes encoding cytokines in the context of cardiac surgery. Part I: Heart transplantation
por: Danikiewicz, Aleksander, et al.
Publicado: (2015) -
CHA(2)DS(2)-Vasc score and CHA(2)DS(2)-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
por: Zhao, Sheng Gang, et al.
Publicado: (2019)